期刊文献+

1118例早孕药物流产效果影响因素的研究 被引量:7

Influencing factors of early medical abortion outcomes in 1 118 cases
下载PDF
导出
摘要 目的探讨影响药物流产效果的相关因素,以便更好地指导临床用药。方法选择2009年1月至2012年10月于上海市松江区九亭医院妇产科门诊就诊的患者,以药物流产后因不全流产或流产失败行手术干预的患者为病例组,药物流产后流产完全的患者为对照组,分析药物流产后需要手术干预的相关影响因素。结果孕妇的年龄(OR=1.34,χ^2=2.97,P〉0.05)、剖宫产史(DR=1.34,χ^2=3.60,P〉0.05)、流产史(χ^2=3.35,P〉0.05)与手术干预率没有显著关系;孕妇的妊娠史(χ^2=19.50,P〈0.01)、药流前B超显示的孕囊平均直径(DR=2.04,χ^2=19.20,P〈0.05)、子宫位置(OR=3.53,χ^2=39.57,P〈0.05)与手术干预率有显著关系。结论孕妇的妊娠史、药流前B超示孕囊平均直径、屈位子宫是影响早孕药物流产成功的主要因素。 Objective To investigate the correlative factors of affecting the outcomes of early medical abortion, so as to provide basis for clinical medication. Methods Out-patient cases treated in Jiuting Hospital of Songjiang District between January 2009 and October 2012 were selected. Women suffering from failed medical abortion and requiring an additional surgical treatment were enrolled in case group, while women with successful abortion were enrolled in control group. The correlative influencing factors of medical abortion requiring additional surgical treatment were evaluated. Results The age of women ( OR = 1.34, χ^2 = 2.97, P 〉 0. 05 ), history of caesarean section ( OR = 1.34, χ^2 = 3.60, P 〉 0.05 ), and history of abortion (χ^2= 3.35, P 〉 0.05 ) did not have significant relationship with surgical treatment rate, but the history of pregnancy (χ^2= 19.50 ,P 〈 0.01 ), the average diameter of gestational sac revealed by B-uhrasonography ( OR = 2.04, χ^2 = 19.2, P 〈 0.05 ) and the position of uterus ( OR = 3.53 ,χ^2= 39.57, P 〈 0.05 ) had significant relationship. Conclusion The history of pregnancy, the average diameter of gestational sac revealed by B-ultrasonography and the uterine flexion are the primary factors that influence the outcomes of early medical abortion.
出处 《中国妇幼健康研究》 2013年第3期378-380,共3页 Chinese Journal of Woman and Child Health Research
关键词 米非司酮 米索前列醇 药物流产 手术干预 mifepristone misoprostol medical abortion surgical treatment
  • 相关文献

参考文献4

二级参考文献12

  • 1Wiebe E, Dunn S, Guilbert E, et al. Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol [J]. Obstet Gynecol, 2002,99(5) :813-819.
  • 2Jain JK, Dutton C, Harwood B, et al. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy[J]. Hum Reprod, 2002, 17 (6) : 1477-1482.
  • 3Leonhardt SA, Edwards DP. Mechanism of action of progesterone antagonists. Exp Bid, 2002, 227(11):969-80.
  • 4Tang OS, Ho PC. Clinical applications of mifepristone, Int Soc Gynecol Endocrinol, 2006,22(12):655-9.
  • 5Chan CC, Lao TT, Ho PC, et al. The effect of mifepristone on the expression of steroid hormone receptors in human decidua and placenta: a randomized placebo-controlled double-blind study. Clin Endocrinol Metab, 2003, 88(12):5 846-50.
  • 6Zhang W, Mazella J, Kloosterboer HJ, et al. Progestagenic effect of tibolone are target gene-specific in human endometrial cells. Soc Gynecol Inves, 2006, 13(6):459-65.
  • 7Hartt LS, Carling S J, Jovce MM, et al. Temporal and spatial associations of oestrogen receptor and progesterone receptor in the endometrium of cyclic and early pregnant mares. Reproduction, 2005, 130(2):241-50.
  • 8Powell SA, Smith BB, Timm KL, et al. Expression of estrogen receptors in the corpus luteum and uterus from non- pregnant and pregnant llamas. Mol Reprod Dev, 2007, 74(8):1 043-52.
  • 9Zhang S, Jonklaas J, Danielsen M, et al.The glucocorticoid agonist activities of mifepristone and progesterone are dependent on glucocorticoid receptor levels but not on EC 50 values. Steroids, 2007, 72(6-7):600-8.
  • 10高佩佩,汪平.剖宫产后早孕药流及重复药流213例临床分析[J].生殖与避孕,2000,20(2):87-91. 被引量:10

共引文献70

同被引文献82

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部